NSIM
ANRO icon

North Star Investment Management’s Alto Neuroscience ANRO Stock Holding History

North Star Investment Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-174
Closed -$3.1K – 1806
2025
Q4 		$3.1K Hold
174
– – ﹤0.01% 1223
2025
Q3 		$699 Buy
+174
New +$577 ﹤0.01% 1195

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

North Star Investment Management's ANRO Position: Q1 2026 in Review

North Star Investment Management sold out of Alto Neuroscience (ANRO) in Q1 2026, closing a stake of 174 shares — an estimated $3.1K sold.

North Star Investment Management first reported a position in ANRO in Q3 2025 and held it in 2 quarters. The position peaked at $3.1K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • North Star Investment Management reported no remaining Alto Neuroscience position as of Q1 2026 after selling out during the quarter.
  • North Star Investment Management sold 174 Alto Neuroscience shares in Q1 2026, an estimated $3.1K.
  • North Star Investment Management first reported a position in Alto Neuroscience in Q3 2025 and held it in 2 quarters.
  • North Star Investment Management's Alto Neuroscience position peaked at $3.1K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.